CK-MB - India CDSCO Medical Device Registration

CK-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_8a863ab9781ae23a57fffc35f97a621d_07d65532fafe9ee3aff40e7fdb96c080. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

CK-MB

UID: IMP/IVD/2021/000365_8a863ab9781ae23a57fffc35f97a621d_07d65532fafe9ee3aff40e7fdb96c080

Brand Name

AFIAS Infliximab

License Holder

BODITECH MED INDIA PRIVATE LIMITED

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS CK-MB is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Creatine Kinase Isoenzyme-MB (AFIAS Infliximab ) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (AFIAS Infliximab ) and acute coronary syndrome (AFIAS Infliximab )

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

CK-MB

Brand: CRP

DELTA LAB

CK-MB - India CDSCO Medical Device Registration

Brand Name

License Holder

Device Class

Approving Authority

Product Information

DJ Fang

CK-MB

CK-MB

CK-MB

CK-MB

CK-MB

CK-MB

CK-MB

TSH

Progesterone

Myoglobin

TSH

Progesterone

AFIAS-6

Myoglobin

AMH

Testosterone

IL-6

Cardiac Triple

AFIAS Total Anti-Infliximab

AFIAS NORO